33. I.J. Majoros et al., "PAMAM Dendrimer-based Multifunctional Conjugate for Cancer Therapy: Synthesis, Characterization,
and Functionality," Biomacromol. 7 (2), 572–579 (2006).
34. R. Wiwattanapatapee, L. Lomlim, and K. Saramunee. "Dendrimers Conjugates for Colonic Delivery of 5-aminosalicylic Acid,"
J. Controll. Rel. 88 (1), 1–9 (2003).
35. G.M. Dykes, "Dendrimers: A Review of their Appeal and Applications," J. Chem. Technol. Biotechnol.
76 (9), 903–918 (2001).
36. A.T. Florence, "Dendrimers: A Versatile Targeting Platform," Adv. Drug Del. Rev. 57 (15), 2104–2105 (2005).
37. S. Diekmann and T. K. Lindhorst, "Dendrimers," Rev. in Mol. Biotechnol. 90 (3–4), 157–158 (2002).
38. T. Goodson, O. Varnavski, and Y. Wang, "Optical Properties and Applications of Dendrimer-Metal Nanocomposites," Int. Rev. Phy. Chem. 23 (1) 109–150 (2004).
39. C .Dufes, I.F. Uchegbu, and A.G. Schatzlein, "Dendrimers in Gene Delivery," Adv. Drug. Del. Rev.
57 (15), 2177–2202 (2005).
40. R. Esfand and D.A. Tomalia, "Poly(amidoamine) (PAMAM) Dendrimers: From Biomimicry to Drug Delivery and Biomedical Applications,"
Drug Disc. Today
6 (8), 427–436 (2001).
41. V.J. Venditto, C.A. Regino, and M.W. Brechbiel, "PAMAM Dendrimer Based Macromolecules as Improved Contrast Agents," Mol. Pharm. 2 (4), 302–311 (2005).
42. N. Zhu et al., "PAMAM Dendrimers-Based DNA Biosensors for Electrochemical Detection of DNA Hybridization," Electroanalysis
18 (21), 2107–2114 (2006).
43. N. Bourne et al., "Dendrimers, a New Class of Candidate Topical Microbicides with Activity against Herpes Simplex Virus
Infection. Antimicrobial Agents and Chemotherapy," Antimicrob. Agents Chemother.
4 (9) 2471–2474 (2000).
44. H. Zhong et al., "Studies on Polyamidoamine Dendrimers as Efficient Gene Delivery Vector," J. Biomat. Appl.
22 (6), 527–544 (2008).
45. A. Gerald, M.R. Ashton, and E. Khoshdel, "Hydroxyl-Functionalized Dendritic Macromolecules in Topical Cosmetic and Personal
Care Compositions, US Patent 6,582,685, June 23, 2004.
46. F. Tournilhac and S. Pascal, "Cosmetic or Dermatological Topical Compositions Comprising Dendritic Polyesters," US Patent
6,287,552, Sept. 11, 2001.
47. B. Wolf, S. Florence, "Cosmetic Compositions Having Keratolytic and Anti-Acne Activity," US Patent 5,449,519, Sept. 12,
1995.
48. S. Kluijtmans and J.B. Bouwstra, "Dendrimer-Aminobutadiene-Based UV-Screens, European patent 1,784,455, May 16, 2007.
49. W.S. Bahary and M. P. Hogan. "Cleansing Compositions with Dendrimers as Mildness Agents," US Patent 5,658,574, Aug.
19, 1997.
50. S. Forestier, I. Rollat-Corvol, "Deodorant Composition and Use Thereof," US Patent 6,001,342, Dec. 14, 1999.
51. D. Allard and S. Forestier, "Self-Tanning Cosmetic Compositions," US Patent 6,399,048, June 4, 2002.
52. T. F. Vandamme and L. Brobeck, "Poly(amidoamine) Dendrimers as Ophthalmic Vehicles for Ocular Delivery of Pilocarpine
Nitrate and Tropicamide," J. Control. Rel. 102 (1), 23–38 (2005).
53. S. Shaunak et. al., "Polyvalent Dendrimer Glucosamine Conjugates Prevent Scar Tissue Formation," Nature Biotechnol.
22 (8), 977–984 (2004).
54. R. J. Marano et al., "Dendrimer Delivery of an Anti-VEGF Oligonucleotide into the Eye: A Long-Term Study into Inhibition
of Laser-Induced CNV, Distribution, Uptake, and Toxicity," Gene Ther. 12 (1), 1544–1550 (2005).
55. Y. Cheng et al., "Transdermal Delivery of Nonsteroidal Anti-Inflammatory Drugs Mediated by Polyamidoamine (PAMAM) Dendrimers,"
J. Pharm. Sci.
96 (3), 595–602 (2007).
56. A. S. Chauhan et al., "Dendrimer-Mediated Transdermal Delivery: Enhanced Bioavailability of Indomethacin," J. Control. Rel.
90 (3), 335–343 (2003).
57. "Starpharma Reports Positive Vivagel Clinical Study Results," Starpharma Holdings Limited (Melbourne, Australia), available
at
http://www.starpharma.com/, accessed Oct. 13, 2008.
58. "Avidimer Technology Overview," Avidimer Therapeutics (Ann Arbor, MI), available at
http://www.avidimer.com/, accessed Oct. 13, 2008.
59. Nanotechnology Characterization Laboratory, National Cancert Institute, "Dendrimer-Based MRI Contrast Agents," (Frederick,
MD, Dec. 2006), available at http://ncl.cancer.gov/120406.pdf, accessed Oct. 13, 2008.
60. "Starburst PAMAM Dendrimers," Dendritic Nanotechnologies Inc. (Mount Pleasant, MI), available at
http://www.dnanotech.com/, accessed at Oct. 13, 2008.
61. NanoJuice Transfection Reagent Kit, EMD Biosciences (Gibbstown, NJ), available at
http://www.emdbiosciences.com/html/NVG/nanojuice.htm, accessed Oct. 13, 2008.
|
